Literature DB >> 33307924

Transparency in reporting of phase 3 cancer clinical trial results.

Roshal R Patel1,2, Vivek Verma1, Clifton D Fuller1, Zachary R McCaw3, Ethan B Ludmir1.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 33307924      PMCID： PMC7951952          DOI： 10.1080/0284186X.2020.1856410

Source DB:  PubMed          Journal:  Acta Oncol        ISSN： 0284-186X            Impact factor:   4.089


× No keyword cloud information.
  14 in total

1.  Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles.

Authors:  An-Wen Chan; Asbjørn Hróbjartsson; Mette T Haahr; Peter C Gøtzsche; Douglas G Altman
Journal:  JAMA       Date:  2004-05-26       Impact factor: 56.272

2.  Editorial review of protocols for clinical trials.

Authors:  J P Siegel
Journal:  N Engl J Med       Date:  1990-11-08       Impact factor: 91.245

3.  Statistics in medicine--reporting of subgroup analyses in clinical trials.

Authors:  Rui Wang; Stephen W Lagakos; James H Ware; David J Hunter; Jeffrey M Drazen
Journal:  N Engl J Med       Date:  2007-11-22       Impact factor: 91.245

4.  Selective reporting in clinical trials: analysis of trial protocols accepted by The Lancet.

Authors:  Sanaa Al-Marzouki; Ian Roberts; Stephen Evans; Tom Marshall
Journal:  Lancet       Date:  2008-07-19       Impact factor: 79.321

5.  Statistical controversies in clinical research: comparison of primary outcomes in protocols, public clinical-trial registries and publications: the example of oncology trials.

Authors:  A S Perlmutter; V-T Tran; A Dechartres; P Ravaud
Journal:  Ann Oncol       Date:  2017-04-01       Impact factor: 32.976

Review 6.  Comparison between publicly accessible publications, registries, and protocols of phase III trials indicated persistence of selective outcome reporting.

Authors:  Sheng Zhang; Fei Liang; Wenfeng Li
Journal:  J Clin Epidemiol       Date:  2017-07-27       Impact factor: 6.437

7.  Association of Trial Registration With Reporting of Primary Outcomes in Protocols and Publications.

Authors:  An-Wen Chan; Annukka Pello; Jessica Kitchen; Anna Axentiev; Jorma I Virtanen; Annie Liu; Elina Hemminki
Journal:  JAMA       Date:  2017-11-07       Impact factor: 56.272

8.  Comparison of protocols and registry entries to published reports for randomised controlled trials.

Authors:  Kerry Dwan; Douglas G Altman; Lynne Cresswell; Michaela Blundell; Carrol L Gamble; Paula R Williamson
Journal:  Cochrane Database Syst Rev       Date:  2011-01-19

9.  SPIRIT 2013 statement: defining standard protocol items for clinical trials.

Authors:  An-Wen Chan; Jennifer M Tetzlaff; Douglas G Altman; Andreas Laupacis; Peter C Gøtzsche; Karmela Krleža-Jerić; Asbjørn Hróbjartsson; Howard Mann; Kay Dickersin; Jesse A Berlin; Caroline J Doré; Wendy R Parulekar; William S M Summerskill; Trish Groves; Kenneth F Schulz; Harold C Sox; Frank W Rockhold; Drummond Rennie; David Moher
Journal:  Ann Intern Med       Date:  2013-02-05       Impact factor: 25.391

10.  Discrepancies in sample size calculations and data analyses reported in randomised trials: comparison of publications with protocols.

Authors:  An-Wen Chan; Asbjørn Hróbjartsson; Karsten J Jørgensen; Peter C Gøtzsche; Douglas G Altman
Journal:  BMJ       Date:  2008-12-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.